In 2020, Ghana's switched from ROTARIX to ROTAVAC in its routine immunization program in order to save money and cold chain space. An economic analysis of this switch, conducted by PATH, the University of Ghana, and Ghana Health Service, found that the switch was indeed cost-saving for Ghana. The results may be of interest to other countries considering similar rotavirus vaccine product switches.
In 2020, Ghana switched from using ROTARIX® to ROTAVAC® in its national immunization program. PATH worked with Ghana Health Service and the University of Ghana to analyze the economic implications of this switch. These four fact sheets explore the key results of these analyses, collectively providing a case study on Ghana’s rotavirus vaccine product switch.
(Manuscript pending submission to a peer-reviewed journal.)
Corporate author(s): PATH
Publication date: May 2022
Année de publication
2022
PORTFOLIO-LESSONS
Cette ressource apparaît sur le Thème suivant:
Cette ressource est incluse dans le tableau suivant:
| Titre | Auteur | Année | Type | Langue |
|---|
| The switch from ROTARIX to ROTAVAC in Ghana: Answers to four key questions | PATH | 2022 | Report | Anglais |
| The Health Benefits of Rotavirus Immunization for Children in Palestine: Results of a Vaccine Impact Analysis | PATH, Rostropovich-Vishnevskaya Foundation, Palestine Ministry of Health | 2021 | Report | Russe |
| Economic Implications of Switching Rotavirus Vaccine Products in Palestine's Immunization Program | PATH | 2020 | Case study | Arabe, Anglais, Russe, Français |
| Introducing 5-dose Measles-Rubella Vaccine Vials in Zambia: Research Findings | Dose Per Container Partnership (DPCP), JSI | 2019 | Case study | Anglais |
| The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in Zambia | Kirstin Krudwig, Barbara Knittel, Ali Karim, Natasha Kanagat, Wendy Prosser, Guissimon Phiri, Frances Mwansa, Robert Steinglass | 2020 | Journal article | Anglais |
| A Switch for Sustainability in Ghana's Rotavirus Vaccine Program | George Armah | 2020 | Case study | Anglais |
| The Operational Impact of Switching from a Two-Dose to a One-Dose HPV Vaccination Schedule: Lessons Learned from Burkina Faso, Ethiopia, and Solomon Islands | PATH | 2025 | Report | Anglais |
| Economic implications of switching to the hexavalent infant vaccine in an immunization program in India | Pawan Kumar, Kapil Singh, Arindam Ray, Arup Deb Roy, Susmita Chatterjee, Homero Hernandez, Amrita Kumari | 2026 | Journal article | Anglais |
Ajouté par: Laura Kallen
Ajouté le: 2022-05-25 08:14:00
Consultations: 2190
